Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Richette

Showing results (281-290 of 307) with videos related to

Pageof 31
Sort By:
Rheumatology (Oxford, England)|January 3, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyClementina López-Medina, Clémence Gorlier, Ana-Maria Orbai, et al.
Arthritis Care & Research|October 15, 2019
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen CountriesAna-Maria Orbai, Jamie Perin, Clémence Gorlier, et al.
Rheumatology (Oxford, England)|November 24, 2020
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparisonJean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Drugs & Aging|June 19, 2015
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and FrailtyNigel Arden, Pascal Richette, Cyrus Cooper, et al.
The Journal of Infection|December 23, 2023
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registryDamien Caillet Portillo, Xavier Puéchal, Maëva Masson, et al.
Joint Bone Spine|October 19, 2025
Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung diseasePierre-Antoine Juge, Marie-Pierre Debray, Valérie Devauchelle Pensec, et al.
The Lancet. Rheumatology|December 11, 2025
Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trialAlice Courties, Sophie Tuffet, Grégoire Cormier, et al.
Annals of the Rheumatic Diseases|November 5, 2025
EULAR 2025 classification criteria for haemochromatosis arthropathyPatrick Dw Kiely, Stephanie Finzel, Bayram Farisogullari, et al.
Pageof 31

Showing results (281-290 of 307) with videos related to

Sort By:
Pageof 31
Rheumatology (Oxford, England)|January 3, 2025
Variability of Psoriatic Arthritis Impact of Disease questionnaire (PsAID12) thresholds in psoriatic arthritis: data from the ReFlaP studyClementina López-Medina, Clémence Gorlier, Ana-Maria Orbai, et al.
Arthritis Care & Research|October 15, 2019
Determinants of Patient-Reported Psoriatic Arthritis Impact of Disease: An Analysis of the Association With Sex in 458 Patients From Fourteen CountriesAna-Maria Orbai, Jamie Perin, Clémence Gorlier, et al.
Rheumatology (Oxford, England)|November 24, 2020
Secukinumab and ustekinumab treatment in psoriatic arthritis: results of a direct comparisonJean-Guillaume Letarouilly, Benoît Flachaire, Céline Labadie, et al.
Annals of the Rheumatic Diseases|December 25, 2012
Efficacy of rituximab in systemic manifestations of primary Sjogren's syndrome: results in 78 patients of the AutoImmune and Rituximab registryJacques-Eric Gottenberg, Gael Cinquetti, Claire Larroche, et al.
Joint Bone Spine|May 1, 2012
Abatacept therapy and safety managementThao Pham, Hervé Bachelez, Jean-Marie Berthelot, et al.
Drugs & Aging|June 19, 2015
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and FrailtyNigel Arden, Pascal Richette, Cyrus Cooper, et al.
The Journal of Infection|December 23, 2023
Diagnosis and treatment of Tropheryma whipplei infection in patients with inflammatory rheumatic disease: Data from the French Tw-IRD registryDamien Caillet Portillo, Xavier Puéchal, Maëva Masson, et al.
Joint Bone Spine|October 19, 2025
Baseline characteristics of the TRANSLATE2 cohort: A prospective study on rheumatoid arthritis-associated interstitial lung diseasePierre-Antoine Juge, Marie-Pierre Debray, Valérie Devauchelle Pensec, et al.
The Lancet. Rheumatology|December 11, 2025
Transcutaneous auricular vagus nerve stimulation versus sham stimulation in patients with erosive hand osteoarthritis (ESTIVAL): a randomised, multicentre, double-blind, sham-controlled trialAlice Courties, Sophie Tuffet, Grégoire Cormier, et al.
Annals of the Rheumatic Diseases|November 5, 2025
EULAR 2025 classification criteria for haemochromatosis arthropathyPatrick Dw Kiely, Stephanie Finzel, Bayram Farisogullari, et al.
Pageof 31